CEACAM5 抗体
Quick Overview for CEACAM5 抗体 (ABIN108734)
抗原
See all CEACAM5 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
- 
    - 
                                            特异性
- Anti-human CEACAM5 (CEA, CD66e)
- 
                                            纯化方法
- Protein G
- 
                                            免疫原
- immunisation with extracted protein of CEACAM5
- 
                                            亚型
- IgG2a
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- 
                        Flow cytometry: 1.2 µg/10^6 cells 
 ELISA: 1:200 - 1:400
 CELISA: 1:200 Western blot: 4 µg/mL
 Immunohistology: 1-2 µg/10^6 cells (on cryosections)
 For each application a titration should be performed to determine the optimal concentration.
- 
                                            说明
- 
                        Synonyms: CD66e, CEA 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            浓度
- 1 mg/mL
- 
                                            缓冲液
- PBS, pH 7.2
- 
                                            注意事项
- Avoid repeated freezing and thawing.
- 
                                            储存条件
- 4 °C
- 
                                            储存方法
- short term: 2 °C - 8 °C, long term: -20 °C
 
- 
                                            
- 
    - CEACAM5 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5))
- 
                                            别名
- CEACAM5
- 
                                            背景
- CEACAM5 or CEA is the name-giving member of the CEACAM family. CEACAM5 is used as a tumor marker for early detection of recurrent disease and is a potential target of tumor imaging, drugs and immunotargeting. 26/5/1 can be used to distinguish CEACAM5 from all other CEACAM and probably all pregnancy-specific glycoproteins molecules.
- 
                                            UniProt
- P06731
 抗原
- 
                    
 
                                     
                                     
                                    